Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Raw Data Review and Cross-Verification – V 2.0

Posted on By

API Manufacturing: SOP for Raw Data Review and Cross-Verification – V 2.0

Standard Operating Procedure for Raw Data Review and Cross-Verification in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/187/2025
Supersedes SOP/API/187/2022
Page No. Page 1 of 15
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define the procedure for thorough review and cross-verification of raw data generated during production and quality control of Active Pharmaceutical Ingredients (APIs), ensuring the accuracy, completeness, consistency, and integrity of data in compliance with Good Manufacturing Practices (GMP).

2. Scope

This SOP applies to all GMP-related raw data generated in manufacturing, in-process testing, quality control, calibration, and

cleaning validation processes. It includes review of electronic and manual records by designated personnel prior to batch release.

3. Responsibilities

  • QC/Production Personnel: Generate and record raw data as per applicable SOPs.
  • Section Head (QC/Production): Performs initial data verification and correction (if any) with justification.
  • QA Department: Performs cross-verification of raw data against primary documents, test reports, and logs.
See also  API Manufacturing: SOP for Investigation of Out-of-Trend (OOT) Results - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring raw data review and verification are conducted systematically to maintain data integrity across the organization.

5. Procedure

5.1 Definition of Raw Data

  1. Raw data refers to original records or certified copies containing actual observations and results of activities performed, including:
    • Instrument printouts (e.g., HPLC chromatograms, FTIR spectra)
    • Logbooks and worksheets
    • Electronic files (audit trailed)
    • Calibration records and cleaning logs

5.2 Documentation Requirements

  1. All raw data must be:
    • Legible, dated, and signed
    • Recorded in permanent ink (for manual data)
    • Free from overwriting; corrections must be signed and justified
  2. Electronic data must be stored on validated systems with secure access and audit trails.

5.3 Review of Raw Data (Manual and Electronic)

  1. QA or designated reviewer shall:
    • Verify test results match reported values in CoA and summary sheets
    • Check that all required entries are made and signed
    • Confirm traceability of sample ID, batch number, and analytical method
    • Review instrument-generated data against analytical worksheets
  2. Discrepancies, missing data, or unexplained deviations shall be addressed using a Raw Data Discrepancy Form (Annexure-1).

5.4 Cross-Verification of QC Data

  1. Verify the following:
    • System suitability test results
    • Integration parameters and peak areas
    • Retention time and resolution
    • Result calculation and dilution factors
    • Reference standard usage logs
  2. Cross-check electronic data entries (e.g., in LIMS) with hard copies and audit trails.
See also  API Manufacturing: SOP for Transfer of Wet Cake for Drying - V 2.0

5.5 Cross-Verification of Production Data

  1. Review BMR entries:
    • Yield calculations
    • Material dispensing log against issued quantity
    • Equipment usage and cleaning records
    • Process parameters vs. defined limits
  2. Compare batch numbers, labels, and logbook entries for consistency.

5.6 Handling and Documentation of Discrepancies

  1. If any discrepancies or gaps are found:
    • Record in Raw Data Discrepancy Log (Annexure-2)
    • Investigate and justify corrections, if acceptable
    • For critical errors, raise a deviation report and inform QA Head

5.7 Approval and Archival

  1. Once reviewed, QA shall sign the reviewed data pages or verification sheet and archive all reviewed raw data.
  2. Store original data in a secure location with controlled access. Electronic data must be archived as per data retention SOP.

6. Abbreviations

  • QA: Quality Assurance
  • QC: Quality Control
  • CoA: Certificate of Analysis
  • BMR: Batch Manufacturing Record
  • FTIR: Fourier Transform Infrared Spectroscopy
  • LIMS: Laboratory Information Management System
  • SOP: Standard Operating Procedure

7. Documents

  1. Raw Data Discrepancy Form (Annexure-1)
  2. Raw Data Discrepancy Log (Annexure-2)
  3. Review and Verification Checklist (Annexure-3)
See also  API Manufacturing: SOP for Sampling of Viscous and Sticky Materials - V 2.0

8. References

  • ICH Q7 – Section 6: Documentation
  • 21 CFR Part 211.194 – Laboratory Records
  • MHRA Data Integrity Guidance
  • ALCOA+ Principles of Data Integrity

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Raw Data Discrepancy Form

Date Reference No. Description of Discrepancy Action Taken Reviewed By
12/04/2025 QC/2025/032 Missing signature on FTIR report Signed post-verification Sunita Reddy

Annexure-2: Raw Data Discrepancy Log

Sr. No. Date Area Nature of Discrepancy Deviation No. (if any)
001 10/04/2025 QC Incorrect calculation in assay report DEV/2025/04

Annexure-3: Review and Verification Checklist

Parameter Checked (Yes/No) Remarks
Data complete and legible Yes All pages reviewed
Entries signed and dated Yes Compliant
Audit trail checked Yes No irregularities found

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial version New SOP QA Head
14/04/2025 2.0 Integrated electronic audit trail review steps Data Integrity Enhancement QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Aerosol: SOP for Preparing Equipment Maintenance Schedules – V 2.0
Next Post: BA-BE Studies: SOP for Change Control in Bioanalytical Method – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version